SlideShare a Scribd company logo
Dr Bachar RAAD MD, FACS. 
RCMC Yanbu 
Surgical Club 
DEC.2014.
Epidemiology: 
In the world, CRC is the third most common cause of cancer 
death, responsible for 639000 death annually.(1) 
In USA 1 in every 17 people will develop CRC at some point in 
life.(2) 
Incidence in men is 61 per 100,000 as compared to 45 per 
100,000 females. 
Distribution of colon cancer is 18% in right colon , 9 % 
transverse colon , 5% descending colon, 25% sigmoid colon, 
and 43% in the rectum 
1- World health organization mortality database. World health organization. (Accessed 9 Dec 2009.) 
2- Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA cancer J Clin. 2009;59:225-49.
Etiology 
Dietary constituents and supplements: Dietary fat, Red 
meat, Alcohol, Fruits and Vegetable, Fiber, Calcium and 
Vit. D, Folate, Aspirin and NSAI drugs. 
Obesity with an up to twofold increased risk of CRC. 
Physical activity: greater PA is associated with reduced 
risk of CRC. 
Smoking with two to threefold elevation of adenoma risk. 
Cholecystectomy: the association with CRC in 
inconsistent, but seems to be strongest for cancer of the 
proximal colon. 
Inflammatory bowel disease and family history: ulcerative 
colitis, crohn, polyposis.
Screening 
There is clear evidence that CRC can be 
prevented by detecting and removing 
adenomatous polyps and that detecting 
early stage cancers reduce mortality from 
the disease.* 
* Newcomb P, Norfleet R, Storer B, Surawicz T, Marcus P. Screening sigmoidoscopy and colorectal cancer mortality. J 
Natl Cancer inst. 1992;84:1572-5.
Screening 
2008, US Preventive 
Task Force recommendation. 
2008, US Preventive Task Force recommendation.
Clinical presentation 
In symptomatic patients the most common presenting symptoms are: 
1- Abdominal pain (most common). 
2- Change in bowel habits. 
3- Rectal bleeding and occult blood in stool.* 
*-Breat RW, Steel GD, Merck HR, et al. Manengement and survival of patients 
with adenocarcinoma of colon and rectum. J Am Coll Surg.1995;181:225-36
Staging and Prognostic factors 
The original staging system for colorectal cancer was reported by 
Cuthbert Dukes’ in 1930 and it has three stages A,B and C. 
Modified Dukes’. 
Subdividing Dukes’. 
Astler-coller modification.
Staging and Prognostic factors 
TNM staging is the system developed by the American joint 
committee of cancer. 
T 
Tis : carcinoma in situ. 
T1 : Invasion into submucosa. 
T2 : Invasion into muscularis propria. 
T3 : invasion into subserosa. 
T4 : Invasion to other organs. 
N 
N0 : No Lymph nodes / N1 : 1-3 Lymph nodes/ N2: >4 Lymph nodes 
M 
M0 : No metastasis / M1 : Distant metastasis
Staging and Prognostic factors 
Typically, the combination of T, N, and M will lead to 
one of the four stages based on the combination of 
findings. 
Stage 0 Tis, N0, M0. 
Stage 1 T1 or T2, N0, M0. 
Stage 2 T3 or T4, N0, M0. 
Stage 3 any T, N1 or N2, M0. 
Stage 4 any T, any N, M1.
Staging and Prognostic factors 
In addition to TNM staging, the histologic grade of the tumor as 
well as the completeness of the resection should be assessed. 
The absence or presence of residual tumor following resection is 
designated by the letter R, as indicated below, and should be 
indicated in the operative report: 
• R0—complete tumor resection with all margins histologically 
negative 
• R1—incomplete tumor resection with microscopic 
surgical resection margin involvement (margins grossly 
uninvolved) 
• R2—incomplete tumor resection with gross residual 
tumor that was not resected (primary tumor, regional 
nodes, macroscopic margin involvement).* 
*-Nelson H, Petrelli N, Carlin A, et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst. 
2001;93:583–596.
Clinical Prognostic Factors 
 Age, as many cancers, colon cancer incidence 
increases with increasing age. 
 Symptoms, obstruction and perforation are 
poor prognostic signs, overall 5-years survival 
is 33%.* 
 Blood transfusion, can cause immuno 
suppression. 
 Adjacent organ involvement. 
*-Chen HS, Sheen-Chen SM, obstruction and perforation in colo rectal 
adenocarcinoma, analysis of prognosis. Surgery, 2000;127:370-6.
Histologic Factors 
 Histologic grade, poorly differentiated tumors have a 
worse prognosis stage for stage compared to better 
differentiated tumors.* 
 Tumor budding, undifferentiated portion of tumors at 
the leading invasive edge, associated with a high risk 
of recurrence.* 
 Mucin production; Signet-cell histology. 
 Venous, perineural, lymph nodes invasion. 
 Positive margins. 
*-Cooper HS, Slemmer JR, Surgical pathology af carcinoma of colon and rectum. Semin oncol. 1991;18:367-80. 
*- Nakamura T, Mitomi H, Kickuchi S, et al. evaluation of use fullness of tumor budding on the prediction of 
metastases to the lungs and liver after curative excision of colorectal cancer, Hepatogastroenterology, 2005;52:1432- 
5.
Carcinoembryonic Antigen, CEA.* 
 A glycoprotein absent in normal mucosa, but present in 
97% of patients with colo-rectal cancer. 
 Patients with disease confined to mucosa and sub 
mucosa will have elevated CEA level in 40-60% of cases. 
 If CEA level does not fall postoperatively then occult 
metastases may be present, (adj therapy). 
 A CEA level greater than 15 mg/ml predicts an 
increasing risk of metastases. 
 A normal CEA level preoperative may become elevated 
with metastases or recurrences. 
*- The standard practice task force, The American Society of Colon and Rectal Surgeons. Practice 
parameters for the surveillance and follow up of patients with colo rectal cancer. Dis Colon Rectum, 
2004;47:807-17.
Preoperative Preparation 
The tow most important prognostic indicators remain the 
degree of bowel wall invasion and status of the lymph nodes. 
Effective preparation requires knowledge of patient’s 
physiologic status, tumor location, and clinical stage.
Preoperative Preparation 
.
Preoperative Preparation 
Localization of the tumor and its histopathology are 
important in selecting an operative plan and the 
optimal resection margins. 
 Colonoscopy is widely used today and represents 
the optimal means of detecting a cancer. 
 CT allows the localization of lesions, identification 
of local organ invasion and distant metastasis. 
 Endoluminal US and MRI has become extremely 
useful in staging of rectal cancer. 
 Combined PET/CT appears to provide the most 
accurate detection of liver metastases (97%).* 
*-Orlacchio A, Scillaci O, Fusco N, et al. Role of PET/CT in detection of liver metastases from 
colorectal cancer. Radiol Med. 2009;114:571-85.
Preoperative Preparation 
Mechanical cleansing combined with oral 
antibiotics reduces the concentration of 
anaerobic and aerobic bacteria within the 
colon and decreases the incidence of wound 
infection from 35 to 9%.* 
*- Matheson DM, Arabi Y, Baxter-Smith D, et al. Randomized multicentric trial of oral bowel preparation and 
antimicrobials for elective colorectal operations. Br J Surg 1978;65:597-600.
Preoperative Preparation 
 Bucher and al. reviewed 565 patients with mechanical bowel 
preparation versus 579 without a preparation, demontrated a 
higher anastomotic leak rate in the mechanical prep group.* 
 Slim and al. reported an updated review and meta-analysis of 
randomized controlled trials of patients. They found no 
difference between the groups for anastomotic leak rate or the 
incidence of pelvic or abdominal abscess.* 
*- Guenaga KF, Matos D, Castro AA,et al. mechanical bowel preparation for elective colorectal surgery. Cohrane database Syst 
Rev. 2003:CD001544. 
*- Slim K, Vicaut E, Launay savary MV, et al.abdated systematic review and meta analysis of randomized clinical trials on the role 
of bowel preparation before colo rectal surgery. Ann Surgery 2009;249:203-9.
Preoperative Preparation 
While there is no enough data to make 
recomendations for the use of bowel preperation in 
colorectal surgery, we conclude that the routine use 
of mechanical bowel preparation should be 
abondoned, and replaced by liquid diet for three 
days before elective surgery with appopriate 
antimicrobials medications.
Surgical Technique 
The principles of oncologic resection are a wide 
mesenteric resection achieved by ligating the 
feeding artery at its origin with adequate distal and 
proximal margins. 
With the recommendation of a minimum of 12 
lymph nodes should be examined.* 
*-Nelson H, Petrelli N, Carlin A, et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl cancer inst. 
2001;93:583-96.
Surgical Technique 
Right hemi colectomy: the terminal 
ileum should be divided 10-15 cm 
proximal to the ileocecal valve to 
allow for good vascular supply, 
the transverse colon is divided 
to the right of the main trunk of 
the middle colic artery or to the 
left for Extended RT hemi colectomy.
Surgical Technique 
Left hemi colectomy: lateral to medial 
or medial to lateral approach. 
Inferior mesenteric artery should be 
ligated at its origin, and the inferior 
mesenteric vein ligated near the 
ligament of Treitz. 
Identification of the left ureter. 
Bowel transected with at least 5 cm 
proximal margin and distal site 
on the top of the rectum.
Surgical Technique 
Total colectomy with ileorectal anastomosis: 
Applied to circumstances, where the patient has 
been diagnosed with HNPCC, attenuated Familial 
Adenomatous Polyposis, metachronous cancers in 
separate colon segments, and in acute malignant 
distal colon obstructions with unknown status of the 
proximal bowel.
Surgical procedures and principles in rectal 
surgery. 
The result is that primary resection and 
anastomosis without a colostomy or ileostomy 
are the rule rather than exception.
Palliation should be the goal in a patient for 
whom curative resection is not possible: 
 If patient is a reasonable operative risk. 
 If the primary lesion is not resectable. 
 Significant metastatic disease and the 
primary tumor is small.
A colonic stent can be used if the patient 
needs to be relieved of an partial obstruction. 
Stent is just temporary maneuver, patient for 
reevaluation after chemo or chemo-radio 
therapy for diversion or resection.
Variability in outcome in rectal surgery is 
based on: 
 Surgeon and hospital volume. 
 Total mesorectal excision. 
 Distal margins and radial margins. 
 Lateral lymph nodes dissection. 
 Selection of appropriate therapy for rectal 
cancer.
 Surgeon and hospital volume. 
When hospital with highest quartile of volume 
(more than 20 procedures annually) were 
compared with those with lowest quartile 
(fewer than seven procedures annually), 
there were statistically significant differences 
in colostomy rates (29.5 versus 36.6%), 30 
day post operative mortality (1.6 versus 
4.8%), and overall 2 years survival (83.7 
versus 76.6%).* 
* Hodgson DC, Zhang W, Zaslavsky AM, et al. Relation of hospital volume to colostomy rates and survival for patients with rectal 
cancer. J Natl cancer inst. 2003;95:(01):708-16.
 Total mesorectal excision.
 Total mesorectal excision. 
Post operative impotence and retrograde 
ejaculation or both have been observed in 25- 
75% of cases when blunt dissection done causing 
damage of pelvic autonomic sympathic and para 
s. nerves. 
By contrast after TME with careful nerve sparing 
dissection, impotence has been reported in 
only 10-29% of cases.* 
*Masui H, Ike H, Yamaguchi S, et al. Male sexual function after autonomic nerve-preserving 
operation for rectal cancer. Dis Colon Rectum, 1996;39(10):1140-5.
 Distal and radial margins 
The first line of rectal cancer spread is upward 
along the lymphatic course. 
A 2-cm distal margin is generally justifiable over 5- 
cm proximal margin. 
A frozen section analysis of the distal margin must 
be performed to comfirm a cancer free margin.
 Lateral lymph nodes dissection 
A complete clearance of lateral lymph nodes 
or extended lateral lymph nodes dissection 
for lying rectal cancer is a controversial 
topic. 
Associated with a much higher rate of urinary 
and sexual dysfunctions as compared to 
standard TME. 
Become a routine practice in Japan.
 Selection of appropriate therapy for Rectal 
Cancer. 
Presently the surgeon has three major curative 
options: 
- Local excision, 
- Sphincter-saving abdominal surgery, 
- Abdominoperineal Resection, APR. 
Each patient with rectal cancer should be 
individually evaluated, and a technical plan is 
customized to their stage, gender, age, and body 
habitus.
T1 invasion into the submucosa. 
T2 invasion into the muscularis 
propria. 
T3 invasion the mesorectal fat. 
T4 invasion of other organs.
Special circumstances 
 Laparoscopic colon resection for Cancer* 
Laparoscopic technique has been used for more 
than 15 years. 
Faster return of bowel function, shorter length of 
stay, less narcotic use. 
Conversion did not have any negative impact on the 
oncologic outcome. 
With adequate experience, laparoscopic colectomy 
for colon cancer is safe and provides similar 
outcomes to open colectomy. 
*- Buunen M, Veldkamp R, Hop W, et al. survival after laparoscopic surgery versus open for colorectal cancer. Lancet oncol, 
2009;10:44-52.
Special circumstances 
 Acute obstruction 
The associated bacterial overgrowth coupled with possible 
impairment of blood flow in the proximal bowel has been 
the primary factors that have classically dictated resection 
and proximal diversion. 
Colonic stent can serve as bridge to elective surgery in 
patient with operable cancer. 
Emergency surgery is associated with operative mortalities 
as high as 23% and reduce quality of life.* 
*- Morino M, Bertello A, Garbarini A, et al. malignant colonic obstruction managed by endoscopic stent decompression followed by laparoscopic 
coloctomy. Surg Endosc 2002;16:1483-7.
Special circumstances 
 Prophylactic Oophorectomy, 
The debate continue regarding the relative risk and 
benefits of a prophylactic oophorectomy in female 
patient with colorectal cancer. 
The risk of micro metastatic implants in the ovary 
increases with tumor stage and approaches the 
10%.* 
*-Mackeigan JM, Ferguson JA. Prophylactic oophorectomy and colorectal cancer in premenopausal 
patients. Dis Colon Rectum 1979;22:401-5.
Special circumstances 
 Colon Cancer and AAA. 
Vascular surgeons preferred to repair the AAA first, 
whereas the nonvascular surgeons preferred colectomy. 
Any aneurysm >6 cm should be repaired first or 
synchronously with the colon resection, to avoid rupture. 
Endo vascular repair followed by colectomy within the 
next couple of days, or under a single anesthetic time, 
and this is being increasingly supported by the 
literature.* 
*-Veraldi GF, Minicozzi A, Genco B, et al. endovascular treatment in patient with AAA and synchronous neoplasm. Chr 
Italy, 2008;60:23-31.
Special circumstances 
 Colon cancer and liver metastases, 
The risk of simultaneous colectomy and hepatectomy do not 
appear to be excessive in selected patients operated by expert 
surgeons, and long term survival rates seem to be similar.* 
16% of previously unresectable patients can be down staged and 
eventually undergo curative resection with as high as 40% 5- 
years survival.* 
When metastatic disease is not resectable, upfront chemotherapy 
without resection of primary lesion may be reasonable approach. 
*- Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases down staged by chemotherapy: a 
model long time survival. Ann Surg. 2004;240:644-57.
Outcome of surgery for colorectal cancer 
 Overall 5-years survival rates after major 
surgery for colorectal cancer are as follow: 
stage I, 85-100%; stage II, 60-80%; stage 
III, 30-50%. 
 The risk of locoregional recurrence following 
colectomy should be below 5%.
Summary 
 Surgery of colonic cancer has been increasingly 
better defined and the data clearly support the 
benefits of wide mesenteric resection, clear 
radial margins, and resection of adherent 
adjacent organs. 
 To allow accurate staging, 12 nodes or more 
should be examined. 
 Attention to surgical detail coupled with 
improved perioperative care strategies, are 
essential to minimize operative morbidity and 
mortality.
THANK YOU…

More Related Content

What's hot

LANDMARK TRIALS IN BREAST CANCER
LANDMARK TRIALS IN BREAST CANCERLANDMARK TRIALS IN BREAST CANCER
LANDMARK TRIALS IN BREAST CANCER
Aaditya Prakash
 
Prostate cancer updates 2021
Prostate cancer updates 2021Prostate cancer updates 2021
Prostate cancer updates 2021
Kanhu Charan
 
Management of Rectal Cancer
Management of Rectal CancerManagement of Rectal Cancer
Management of Rectal Cancer
Subhash Thakur
 
Treatment of CA Ovary
Treatment of CA OvaryTreatment of CA Ovary
Treatment of CA Ovary
Anil Gupta
 
Colon cancer chemotherapy trials
Colon cancer  chemotherapy trialsColon cancer  chemotherapy trials
Colon cancer chemotherapy trials
Cancer surgery By Royapettah Oncology Group
 
CARCINOMA RECTUM MANAGEMENT
CARCINOMA RECTUM MANAGEMENTCARCINOMA RECTUM MANAGEMENT
CARCINOMA RECTUM MANAGEMENT
Nabeel Yahiya
 
Pancreatic Cancer.pptx
Pancreatic Cancer.pptxPancreatic Cancer.pptx
Pancreatic Cancer.pptx
Kiran Ramakrishna
 
Early and locally advanced breast cancer
Early and  locally advanced breast cancerEarly and  locally advanced breast cancer
Early and locally advanced breast cancer
Abhilash Cheriyan
 
RAPIDO TRIAL RECTUM
RAPIDO TRIAL RECTUMRAPIDO TRIAL RECTUM
RAPIDO TRIAL RECTUM
Kanhu Charan
 
Rectal cancer chemo and radiotherapy trials
Rectal cancer chemo and radiotherapy trialsRectal cancer chemo and radiotherapy trials
Rectal cancer chemo and radiotherapy trials
Cancer surgery By Royapettah Oncology Group
 
Neoadjuvant Therapy ca rectum
Neoadjuvant Therapy ca rectum Neoadjuvant Therapy ca rectum
Neoadjuvant Therapy ca rectum
Dr Harsh Shah
 
Cross trial esophagus updated result
Cross trial esophagus updated resultCross trial esophagus updated result
Cross trial esophagus updated result
Bharti Devnani
 
Watch & Wait' in rectal cancer
Watch & Wait' in rectal cancerWatch & Wait' in rectal cancer
Watch & Wait' in rectal cancer
Mauricio Lema
 
Portec trial ppt
Portec trial pptPortec trial ppt
Portec trial ppt
Sailendra Parida
 
Soft tissue sarcoma
Soft tissue sarcomaSoft tissue sarcoma
Soft tissue sarcoma
AlirezaGolchini1
 
Landmark trials in Ovarian Cancer
Landmark trials in Ovarian CancerLandmark trials in Ovarian Cancer
Landmark trials in Ovarian Cancer
Pradeep Dhanasekaran
 
Soft & text trial- an overview
Soft & text trial- an overview Soft & text trial- an overview
Soft & text trial- an overview
Kundan Singh
 
Landmark trials in breast Cancer surgery - NSABP 04,06,MILAN,EORTC 10853, ECO...
Landmark trials in breast Cancer surgery - NSABP 04,06,MILAN,EORTC 10853, ECO...Landmark trials in breast Cancer surgery - NSABP 04,06,MILAN,EORTC 10853, ECO...
Landmark trials in breast Cancer surgery - NSABP 04,06,MILAN,EORTC 10853, ECO...
Dr.Bhavin Vadodariya
 
Radiotherapy in renal tumors
Radiotherapy in renal tumorsRadiotherapy in renal tumors
Radiotherapy in renal tumors
Kanhu Charan
 

What's hot (20)

LANDMARK TRIALS IN BREAST CANCER
LANDMARK TRIALS IN BREAST CANCERLANDMARK TRIALS IN BREAST CANCER
LANDMARK TRIALS IN BREAST CANCER
 
Prostate cancer updates 2021
Prostate cancer updates 2021Prostate cancer updates 2021
Prostate cancer updates 2021
 
Management of Rectal Cancer
Management of Rectal CancerManagement of Rectal Cancer
Management of Rectal Cancer
 
Treatment of CA Ovary
Treatment of CA OvaryTreatment of CA Ovary
Treatment of CA Ovary
 
Soft tissue sarcoma dr mnr
Soft tissue sarcoma dr mnrSoft tissue sarcoma dr mnr
Soft tissue sarcoma dr mnr
 
Colon cancer chemotherapy trials
Colon cancer  chemotherapy trialsColon cancer  chemotherapy trials
Colon cancer chemotherapy trials
 
CARCINOMA RECTUM MANAGEMENT
CARCINOMA RECTUM MANAGEMENTCARCINOMA RECTUM MANAGEMENT
CARCINOMA RECTUM MANAGEMENT
 
Pancreatic Cancer.pptx
Pancreatic Cancer.pptxPancreatic Cancer.pptx
Pancreatic Cancer.pptx
 
Early and locally advanced breast cancer
Early and  locally advanced breast cancerEarly and  locally advanced breast cancer
Early and locally advanced breast cancer
 
RAPIDO TRIAL RECTUM
RAPIDO TRIAL RECTUMRAPIDO TRIAL RECTUM
RAPIDO TRIAL RECTUM
 
Rectal cancer chemo and radiotherapy trials
Rectal cancer chemo and radiotherapy trialsRectal cancer chemo and radiotherapy trials
Rectal cancer chemo and radiotherapy trials
 
Neoadjuvant Therapy ca rectum
Neoadjuvant Therapy ca rectum Neoadjuvant Therapy ca rectum
Neoadjuvant Therapy ca rectum
 
Cross trial esophagus updated result
Cross trial esophagus updated resultCross trial esophagus updated result
Cross trial esophagus updated result
 
Watch & Wait' in rectal cancer
Watch & Wait' in rectal cancerWatch & Wait' in rectal cancer
Watch & Wait' in rectal cancer
 
Portec trial ppt
Portec trial pptPortec trial ppt
Portec trial ppt
 
Soft tissue sarcoma
Soft tissue sarcomaSoft tissue sarcoma
Soft tissue sarcoma
 
Landmark trials in Ovarian Cancer
Landmark trials in Ovarian CancerLandmark trials in Ovarian Cancer
Landmark trials in Ovarian Cancer
 
Soft & text trial- an overview
Soft & text trial- an overview Soft & text trial- an overview
Soft & text trial- an overview
 
Landmark trials in breast Cancer surgery - NSABP 04,06,MILAN,EORTC 10853, ECO...
Landmark trials in breast Cancer surgery - NSABP 04,06,MILAN,EORTC 10853, ECO...Landmark trials in breast Cancer surgery - NSABP 04,06,MILAN,EORTC 10853, ECO...
Landmark trials in breast Cancer surgery - NSABP 04,06,MILAN,EORTC 10853, ECO...
 
Radiotherapy in renal tumors
Radiotherapy in renal tumorsRadiotherapy in renal tumors
Radiotherapy in renal tumors
 

Viewers also liked

Radial Margin Positivity as a Poor Prognostic Factor for Colon Cancer
Radial Margin Positivity as a Poor Prognostic Factor for Colon CancerRadial Margin Positivity as a Poor Prognostic Factor for Colon Cancer
Radial Margin Positivity as a Poor Prognostic Factor for Colon Cancer
Ramzi Amri
 
Colo rectal carcinoma
Colo rectal carcinomaColo rectal carcinoma
Colo rectal carcinoma
Dr./ Ihab Samy
 
Rectal cancer: 2015 Updates
Rectal cancer: 2015  UpdatesRectal cancer: 2015  Updates
Rectal cancer: 2015 Updates
Mohamed Abdulla
 
06 surgical disease colon and rectum tutorial hajhamad m msu
06 surgical disease colon and rectum tutorial hajhamad m msu06 surgical disease colon and rectum tutorial hajhamad m msu
06 surgical disease colon and rectum tutorial hajhamad m msu
Mohammed M. H. Hajhamad
 
Surgery of Rectal Cancer : Potentials and Limitations - Dimitris P. Korkolis
Surgery of Rectal Cancer : Potentials and Limitations - Dimitris P. KorkolisSurgery of Rectal Cancer : Potentials and Limitations - Dimitris P. Korkolis
Surgery of Rectal Cancer : Potentials and Limitations - Dimitris P. Korkolis
Dimitris P. Korkolis
 
London SPECC Sun Myint Course March 2016
London SPECC Sun Myint Course March 2016London SPECC Sun Myint Course March 2016
London SPECC Sun Myint Course March 2016Prof. Arthur Sun Myint
 
GASTRIC CARCINOMA
           GASTRIC CARCINOMA            GASTRIC CARCINOMA
GASTRIC CARCINOMA
drfarhanali2008
 
BALKAN MCO 2011 - D. Sebag-Montefiore - Imaging and local therapy of rectal c...
BALKAN MCO 2011 - D. Sebag-Montefiore - Imaging and local therapy of rectal c...BALKAN MCO 2011 - D. Sebag-Montefiore - Imaging and local therapy of rectal c...
BALKAN MCO 2011 - D. Sebag-Montefiore - Imaging and local therapy of rectal c...European School of Oncology
 
Laparoscopic Low Anterior Resection for Cancer : “Pursued or just Permitted?”...
Laparoscopic Low Anterior Resection for Cancer : “Pursued or just Permitted?”...Laparoscopic Low Anterior Resection for Cancer : “Pursued or just Permitted?”...
Laparoscopic Low Anterior Resection for Cancer : “Pursued or just Permitted?”...
Dimitris P. Korkolis
 
Cancer colo rectal
Cancer colo rectalCancer colo rectal
Cancer colo rectal
la escuela de la vida
 
Rectal cancer MRI (for staging of CA rectum), Dr. Adnan Rashid, MD
Rectal cancer  MRI (for staging of CA rectum), Dr. Adnan Rashid, MDRectal cancer  MRI (for staging of CA rectum), Dr. Adnan Rashid, MD
Rectal cancer MRI (for staging of CA rectum), Dr. Adnan Rashid, MD
Adnan Rashid, MD
 
Gastrointestinal endoscopy
Gastrointestinal endoscopyGastrointestinal endoscopy
Gastrointestinal endoscopy
Durai Ravi
 
Anatomía de región inguinal
Anatomía de región inguinalAnatomía de región inguinal
Anatomía de región inguinal
Pool Meza
 
Carcinoma rectum the complete aproach to how to investigate and treat a case ...
Carcinoma rectum the complete aproach to how to investigate and treat a case ...Carcinoma rectum the complete aproach to how to investigate and treat a case ...
Carcinoma rectum the complete aproach to how to investigate and treat a case ...
nikhilameerchetty
 
Carcinoma stomach
Carcinoma stomachCarcinoma stomach
Carcinoma stomach
Muhammad Saleem
 
Preoperative preparation of patients for surgery
Preoperative preparation of patients for surgeryPreoperative preparation of patients for surgery
Preoperative preparation of patients for surgery
Erum Khateeb
 

Viewers also liked (20)

Radial Margin Positivity as a Poor Prognostic Factor for Colon Cancer
Radial Margin Positivity as a Poor Prognostic Factor for Colon CancerRadial Margin Positivity as a Poor Prognostic Factor for Colon Cancer
Radial Margin Positivity as a Poor Prognostic Factor for Colon Cancer
 
Colo rectal carcinoma
Colo rectal carcinomaColo rectal carcinoma
Colo rectal carcinoma
 
Rectal cancer: 2015 Updates
Rectal cancer: 2015  UpdatesRectal cancer: 2015  Updates
Rectal cancer: 2015 Updates
 
Rotary voloyiannis
Rotary voloyiannisRotary voloyiannis
Rotary voloyiannis
 
06 surgical disease colon and rectum tutorial hajhamad m msu
06 surgical disease colon and rectum tutorial hajhamad m msu06 surgical disease colon and rectum tutorial hajhamad m msu
06 surgical disease colon and rectum tutorial hajhamad m msu
 
Surgery of Rectal Cancer : Potentials and Limitations - Dimitris P. Korkolis
Surgery of Rectal Cancer : Potentials and Limitations - Dimitris P. KorkolisSurgery of Rectal Cancer : Potentials and Limitations - Dimitris P. Korkolis
Surgery of Rectal Cancer : Potentials and Limitations - Dimitris P. Korkolis
 
London SPECC Sun Myint Course March 2016
London SPECC Sun Myint Course March 2016London SPECC Sun Myint Course March 2016
London SPECC Sun Myint Course March 2016
 
GASTRIC CARCINOMA
           GASTRIC CARCINOMA            GASTRIC CARCINOMA
GASTRIC CARCINOMA
 
BALKAN MCO 2011 - D. Sebag-Montefiore - Imaging and local therapy of rectal c...
BALKAN MCO 2011 - D. Sebag-Montefiore - Imaging and local therapy of rectal c...BALKAN MCO 2011 - D. Sebag-Montefiore - Imaging and local therapy of rectal c...
BALKAN MCO 2011 - D. Sebag-Montefiore - Imaging and local therapy of rectal c...
 
Laparoscopic Low Anterior Resection for Cancer : “Pursued or just Permitted?”...
Laparoscopic Low Anterior Resection for Cancer : “Pursued or just Permitted?”...Laparoscopic Low Anterior Resection for Cancer : “Pursued or just Permitted?”...
Laparoscopic Low Anterior Resection for Cancer : “Pursued or just Permitted?”...
 
Gastric Carcinoma
Gastric CarcinomaGastric Carcinoma
Gastric Carcinoma
 
Cancer colo rectal
Cancer colo rectalCancer colo rectal
Cancer colo rectal
 
Rectal cancer MRI (for staging of CA rectum), Dr. Adnan Rashid, MD
Rectal cancer  MRI (for staging of CA rectum), Dr. Adnan Rashid, MDRectal cancer  MRI (for staging of CA rectum), Dr. Adnan Rashid, MD
Rectal cancer MRI (for staging of CA rectum), Dr. Adnan Rashid, MD
 
Colorectal cancer
Colorectal cancerColorectal cancer
Colorectal cancer
 
MCC 2011 - Slide 28
MCC 2011 - Slide 28MCC 2011 - Slide 28
MCC 2011 - Slide 28
 
Gastrointestinal endoscopy
Gastrointestinal endoscopyGastrointestinal endoscopy
Gastrointestinal endoscopy
 
Anatomía de región inguinal
Anatomía de región inguinalAnatomía de región inguinal
Anatomía de región inguinal
 
Carcinoma rectum the complete aproach to how to investigate and treat a case ...
Carcinoma rectum the complete aproach to how to investigate and treat a case ...Carcinoma rectum the complete aproach to how to investigate and treat a case ...
Carcinoma rectum the complete aproach to how to investigate and treat a case ...
 
Carcinoma stomach
Carcinoma stomachCarcinoma stomach
Carcinoma stomach
 
Preoperative preparation of patients for surgery
Preoperative preparation of patients for surgeryPreoperative preparation of patients for surgery
Preoperative preparation of patients for surgery
 

Similar to Colo rectal cancer management

Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Epidemiology...
Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Epidemiology...Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Epidemiology...
Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Epidemiology...European School of Oncology
 
Hereditary Non-Polyposis Colorectal Cancer
Hereditary Non-Polyposis Colorectal CancerHereditary Non-Polyposis Colorectal Cancer
Hereditary Non-Polyposis Colorectal Cancer
drchour
 
Austin Journal of Clinical Case Reports
Austin Journal of Clinical Case ReportsAustin Journal of Clinical Case Reports
Austin Journal of Clinical Case Reports
Austin Publishing Group
 
Minimizing locoregional recurrences in colorectal cancer surgery
Minimizing locoregional recurrences in colorectal cancer surgeryMinimizing locoregional recurrences in colorectal cancer surgery
Minimizing locoregional recurrences in colorectal cancer surgery
Apollo Hospitals
 
Ca pancreas part diagnosis and workup
Ca pancreas part diagnosis and workupCa pancreas part diagnosis and workup
Ca pancreas part diagnosis and workup
Satyajeet Rath
 
gastriccancer.ppt
gastriccancer.pptgastriccancer.ppt
gastriccancer.ppt
Khalidfadol
 
gastriccancer.ppt
gastriccancer.pptgastriccancer.ppt
gastriccancer.ppt
Khalidfadol
 
gastriccancer.ppt
gastriccancer.pptgastriccancer.ppt
gastriccancer.ppt
TyronBn
 
gastriccancer types classified and manage
gastriccancer types classified and managegastriccancer types classified and manage
gastriccancer types classified and manage
ShehinSalim3
 
New Advances in the Treatment of Liver Tumors: Laparoscopic Resections
New Advances in the Treatment of Liver Tumors: Laparoscopic ResectionsNew Advances in the Treatment of Liver Tumors: Laparoscopic Resections
New Advances in the Treatment of Liver Tumors: Laparoscopic Resections
Mills-Peninsula Health Services
 
Carcinoma Pancreas.pptx
Carcinoma Pancreas.pptxCarcinoma Pancreas.pptx
Carcinoma Pancreas.pptx
Dr Kartik Kadia
 
Oncotype dx
Oncotype dxOncotype dx
Oncotype dx
Abhinav Mutneja
 
Advances in the management of pancreatic cancer
Advances in the management of pancreatic cancerAdvances in the management of pancreatic cancer
Advances in the management of pancreatic cancer
Promise Echebiri
 
Cuaj 3-373
Cuaj 3-373Cuaj 3-373
Cuaj 3-373
Sabiruddin Mirza
 
Bridge therapy in hepatocellular carcinoma before liver transplantation
Bridge therapy in hepatocellular carcinoma before liver  transplantationBridge therapy in hepatocellular carcinoma before liver  transplantation
Bridge therapy in hepatocellular carcinoma before liver transplantationRicardo Yanez
 
Gasric cancer
Gasric cancerGasric cancer
Oesophageal cancer osama
Oesophageal cancer osamaOesophageal cancer osama
Oesophageal cancer osama
Osama Elzaafarany, MD.
 
Malignant Neoplasms of Stomach.pptx
Malignant Neoplasms of Stomach.pptxMalignant Neoplasms of Stomach.pptx
Malignant Neoplasms of Stomach.pptx
Pushpa Lal Bhadel
 
IJET-V3I2P22
IJET-V3I2P22IJET-V3I2P22
Breast N C C Nguidlinesms1
Breast N C C Nguidlinesms1Breast N C C Nguidlinesms1
Breast N C C Nguidlinesms1
guest108e832
 

Similar to Colo rectal cancer management (20)

Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Epidemiology...
Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Epidemiology...Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Epidemiology...
Medical Students 2011 - A. Cervantes - GASTROINTESTINAL CANCER - Epidemiology...
 
Hereditary Non-Polyposis Colorectal Cancer
Hereditary Non-Polyposis Colorectal CancerHereditary Non-Polyposis Colorectal Cancer
Hereditary Non-Polyposis Colorectal Cancer
 
Austin Journal of Clinical Case Reports
Austin Journal of Clinical Case ReportsAustin Journal of Clinical Case Reports
Austin Journal of Clinical Case Reports
 
Minimizing locoregional recurrences in colorectal cancer surgery
Minimizing locoregional recurrences in colorectal cancer surgeryMinimizing locoregional recurrences in colorectal cancer surgery
Minimizing locoregional recurrences in colorectal cancer surgery
 
Ca pancreas part diagnosis and workup
Ca pancreas part diagnosis and workupCa pancreas part diagnosis and workup
Ca pancreas part diagnosis and workup
 
gastriccancer.ppt
gastriccancer.pptgastriccancer.ppt
gastriccancer.ppt
 
gastriccancer.ppt
gastriccancer.pptgastriccancer.ppt
gastriccancer.ppt
 
gastriccancer.ppt
gastriccancer.pptgastriccancer.ppt
gastriccancer.ppt
 
gastriccancer types classified and manage
gastriccancer types classified and managegastriccancer types classified and manage
gastriccancer types classified and manage
 
New Advances in the Treatment of Liver Tumors: Laparoscopic Resections
New Advances in the Treatment of Liver Tumors: Laparoscopic ResectionsNew Advances in the Treatment of Liver Tumors: Laparoscopic Resections
New Advances in the Treatment of Liver Tumors: Laparoscopic Resections
 
Carcinoma Pancreas.pptx
Carcinoma Pancreas.pptxCarcinoma Pancreas.pptx
Carcinoma Pancreas.pptx
 
Oncotype dx
Oncotype dxOncotype dx
Oncotype dx
 
Advances in the management of pancreatic cancer
Advances in the management of pancreatic cancerAdvances in the management of pancreatic cancer
Advances in the management of pancreatic cancer
 
Cuaj 3-373
Cuaj 3-373Cuaj 3-373
Cuaj 3-373
 
Bridge therapy in hepatocellular carcinoma before liver transplantation
Bridge therapy in hepatocellular carcinoma before liver  transplantationBridge therapy in hepatocellular carcinoma before liver  transplantation
Bridge therapy in hepatocellular carcinoma before liver transplantation
 
Gasric cancer
Gasric cancerGasric cancer
Gasric cancer
 
Oesophageal cancer osama
Oesophageal cancer osamaOesophageal cancer osama
Oesophageal cancer osama
 
Malignant Neoplasms of Stomach.pptx
Malignant Neoplasms of Stomach.pptxMalignant Neoplasms of Stomach.pptx
Malignant Neoplasms of Stomach.pptx
 
IJET-V3I2P22
IJET-V3I2P22IJET-V3I2P22
IJET-V3I2P22
 
Breast N C C Nguidlinesms1
Breast N C C Nguidlinesms1Breast N C C Nguidlinesms1
Breast N C C Nguidlinesms1
 

Recently uploaded

special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
MIRIAMSALINAS13
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
CarlosHernanMontoyab2
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 

Recently uploaded (20)

special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 

Colo rectal cancer management

  • 1. Dr Bachar RAAD MD, FACS. RCMC Yanbu Surgical Club DEC.2014.
  • 2. Epidemiology: In the world, CRC is the third most common cause of cancer death, responsible for 639000 death annually.(1) In USA 1 in every 17 people will develop CRC at some point in life.(2) Incidence in men is 61 per 100,000 as compared to 45 per 100,000 females. Distribution of colon cancer is 18% in right colon , 9 % transverse colon , 5% descending colon, 25% sigmoid colon, and 43% in the rectum 1- World health organization mortality database. World health organization. (Accessed 9 Dec 2009.) 2- Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA cancer J Clin. 2009;59:225-49.
  • 3. Etiology Dietary constituents and supplements: Dietary fat, Red meat, Alcohol, Fruits and Vegetable, Fiber, Calcium and Vit. D, Folate, Aspirin and NSAI drugs. Obesity with an up to twofold increased risk of CRC. Physical activity: greater PA is associated with reduced risk of CRC. Smoking with two to threefold elevation of adenoma risk. Cholecystectomy: the association with CRC in inconsistent, but seems to be strongest for cancer of the proximal colon. Inflammatory bowel disease and family history: ulcerative colitis, crohn, polyposis.
  • 4. Screening There is clear evidence that CRC can be prevented by detecting and removing adenomatous polyps and that detecting early stage cancers reduce mortality from the disease.* * Newcomb P, Norfleet R, Storer B, Surawicz T, Marcus P. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer inst. 1992;84:1572-5.
  • 5. Screening 2008, US Preventive Task Force recommendation. 2008, US Preventive Task Force recommendation.
  • 6. Clinical presentation In symptomatic patients the most common presenting symptoms are: 1- Abdominal pain (most common). 2- Change in bowel habits. 3- Rectal bleeding and occult blood in stool.* *-Breat RW, Steel GD, Merck HR, et al. Manengement and survival of patients with adenocarcinoma of colon and rectum. J Am Coll Surg.1995;181:225-36
  • 7. Staging and Prognostic factors The original staging system for colorectal cancer was reported by Cuthbert Dukes’ in 1930 and it has three stages A,B and C. Modified Dukes’. Subdividing Dukes’. Astler-coller modification.
  • 8. Staging and Prognostic factors TNM staging is the system developed by the American joint committee of cancer. T Tis : carcinoma in situ. T1 : Invasion into submucosa. T2 : Invasion into muscularis propria. T3 : invasion into subserosa. T4 : Invasion to other organs. N N0 : No Lymph nodes / N1 : 1-3 Lymph nodes/ N2: >4 Lymph nodes M M0 : No metastasis / M1 : Distant metastasis
  • 9. Staging and Prognostic factors Typically, the combination of T, N, and M will lead to one of the four stages based on the combination of findings. Stage 0 Tis, N0, M0. Stage 1 T1 or T2, N0, M0. Stage 2 T3 or T4, N0, M0. Stage 3 any T, N1 or N2, M0. Stage 4 any T, any N, M1.
  • 10. Staging and Prognostic factors In addition to TNM staging, the histologic grade of the tumor as well as the completeness of the resection should be assessed. The absence or presence of residual tumor following resection is designated by the letter R, as indicated below, and should be indicated in the operative report: • R0—complete tumor resection with all margins histologically negative • R1—incomplete tumor resection with microscopic surgical resection margin involvement (margins grossly uninvolved) • R2—incomplete tumor resection with gross residual tumor that was not resected (primary tumor, regional nodes, macroscopic margin involvement).* *-Nelson H, Petrelli N, Carlin A, et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst. 2001;93:583–596.
  • 11. Clinical Prognostic Factors  Age, as many cancers, colon cancer incidence increases with increasing age.  Symptoms, obstruction and perforation are poor prognostic signs, overall 5-years survival is 33%.*  Blood transfusion, can cause immuno suppression.  Adjacent organ involvement. *-Chen HS, Sheen-Chen SM, obstruction and perforation in colo rectal adenocarcinoma, analysis of prognosis. Surgery, 2000;127:370-6.
  • 12. Histologic Factors  Histologic grade, poorly differentiated tumors have a worse prognosis stage for stage compared to better differentiated tumors.*  Tumor budding, undifferentiated portion of tumors at the leading invasive edge, associated with a high risk of recurrence.*  Mucin production; Signet-cell histology.  Venous, perineural, lymph nodes invasion.  Positive margins. *-Cooper HS, Slemmer JR, Surgical pathology af carcinoma of colon and rectum. Semin oncol. 1991;18:367-80. *- Nakamura T, Mitomi H, Kickuchi S, et al. evaluation of use fullness of tumor budding on the prediction of metastases to the lungs and liver after curative excision of colorectal cancer, Hepatogastroenterology, 2005;52:1432- 5.
  • 13. Carcinoembryonic Antigen, CEA.*  A glycoprotein absent in normal mucosa, but present in 97% of patients with colo-rectal cancer.  Patients with disease confined to mucosa and sub mucosa will have elevated CEA level in 40-60% of cases.  If CEA level does not fall postoperatively then occult metastases may be present, (adj therapy).  A CEA level greater than 15 mg/ml predicts an increasing risk of metastases.  A normal CEA level preoperative may become elevated with metastases or recurrences. *- The standard practice task force, The American Society of Colon and Rectal Surgeons. Practice parameters for the surveillance and follow up of patients with colo rectal cancer. Dis Colon Rectum, 2004;47:807-17.
  • 14. Preoperative Preparation The tow most important prognostic indicators remain the degree of bowel wall invasion and status of the lymph nodes. Effective preparation requires knowledge of patient’s physiologic status, tumor location, and clinical stage.
  • 16. Preoperative Preparation Localization of the tumor and its histopathology are important in selecting an operative plan and the optimal resection margins.  Colonoscopy is widely used today and represents the optimal means of detecting a cancer.  CT allows the localization of lesions, identification of local organ invasion and distant metastasis.  Endoluminal US and MRI has become extremely useful in staging of rectal cancer.  Combined PET/CT appears to provide the most accurate detection of liver metastases (97%).* *-Orlacchio A, Scillaci O, Fusco N, et al. Role of PET/CT in detection of liver metastases from colorectal cancer. Radiol Med. 2009;114:571-85.
  • 17. Preoperative Preparation Mechanical cleansing combined with oral antibiotics reduces the concentration of anaerobic and aerobic bacteria within the colon and decreases the incidence of wound infection from 35 to 9%.* *- Matheson DM, Arabi Y, Baxter-Smith D, et al. Randomized multicentric trial of oral bowel preparation and antimicrobials for elective colorectal operations. Br J Surg 1978;65:597-600.
  • 18. Preoperative Preparation  Bucher and al. reviewed 565 patients with mechanical bowel preparation versus 579 without a preparation, demontrated a higher anastomotic leak rate in the mechanical prep group.*  Slim and al. reported an updated review and meta-analysis of randomized controlled trials of patients. They found no difference between the groups for anastomotic leak rate or the incidence of pelvic or abdominal abscess.* *- Guenaga KF, Matos D, Castro AA,et al. mechanical bowel preparation for elective colorectal surgery. Cohrane database Syst Rev. 2003:CD001544. *- Slim K, Vicaut E, Launay savary MV, et al.abdated systematic review and meta analysis of randomized clinical trials on the role of bowel preparation before colo rectal surgery. Ann Surgery 2009;249:203-9.
  • 19. Preoperative Preparation While there is no enough data to make recomendations for the use of bowel preperation in colorectal surgery, we conclude that the routine use of mechanical bowel preparation should be abondoned, and replaced by liquid diet for three days before elective surgery with appopriate antimicrobials medications.
  • 20. Surgical Technique The principles of oncologic resection are a wide mesenteric resection achieved by ligating the feeding artery at its origin with adequate distal and proximal margins. With the recommendation of a minimum of 12 lymph nodes should be examined.* *-Nelson H, Petrelli N, Carlin A, et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl cancer inst. 2001;93:583-96.
  • 21. Surgical Technique Right hemi colectomy: the terminal ileum should be divided 10-15 cm proximal to the ileocecal valve to allow for good vascular supply, the transverse colon is divided to the right of the main trunk of the middle colic artery or to the left for Extended RT hemi colectomy.
  • 22. Surgical Technique Left hemi colectomy: lateral to medial or medial to lateral approach. Inferior mesenteric artery should be ligated at its origin, and the inferior mesenteric vein ligated near the ligament of Treitz. Identification of the left ureter. Bowel transected with at least 5 cm proximal margin and distal site on the top of the rectum.
  • 23. Surgical Technique Total colectomy with ileorectal anastomosis: Applied to circumstances, where the patient has been diagnosed with HNPCC, attenuated Familial Adenomatous Polyposis, metachronous cancers in separate colon segments, and in acute malignant distal colon obstructions with unknown status of the proximal bowel.
  • 24. Surgical procedures and principles in rectal surgery. The result is that primary resection and anastomosis without a colostomy or ileostomy are the rule rather than exception.
  • 25. Palliation should be the goal in a patient for whom curative resection is not possible:  If patient is a reasonable operative risk.  If the primary lesion is not resectable.  Significant metastatic disease and the primary tumor is small.
  • 26. A colonic stent can be used if the patient needs to be relieved of an partial obstruction. Stent is just temporary maneuver, patient for reevaluation after chemo or chemo-radio therapy for diversion or resection.
  • 27. Variability in outcome in rectal surgery is based on:  Surgeon and hospital volume.  Total mesorectal excision.  Distal margins and radial margins.  Lateral lymph nodes dissection.  Selection of appropriate therapy for rectal cancer.
  • 28.  Surgeon and hospital volume. When hospital with highest quartile of volume (more than 20 procedures annually) were compared with those with lowest quartile (fewer than seven procedures annually), there were statistically significant differences in colostomy rates (29.5 versus 36.6%), 30 day post operative mortality (1.6 versus 4.8%), and overall 2 years survival (83.7 versus 76.6%).* * Hodgson DC, Zhang W, Zaslavsky AM, et al. Relation of hospital volume to colostomy rates and survival for patients with rectal cancer. J Natl cancer inst. 2003;95:(01):708-16.
  • 29.  Total mesorectal excision.
  • 30.  Total mesorectal excision. Post operative impotence and retrograde ejaculation or both have been observed in 25- 75% of cases when blunt dissection done causing damage of pelvic autonomic sympathic and para s. nerves. By contrast after TME with careful nerve sparing dissection, impotence has been reported in only 10-29% of cases.* *Masui H, Ike H, Yamaguchi S, et al. Male sexual function after autonomic nerve-preserving operation for rectal cancer. Dis Colon Rectum, 1996;39(10):1140-5.
  • 31.  Distal and radial margins The first line of rectal cancer spread is upward along the lymphatic course. A 2-cm distal margin is generally justifiable over 5- cm proximal margin. A frozen section analysis of the distal margin must be performed to comfirm a cancer free margin.
  • 32.  Lateral lymph nodes dissection A complete clearance of lateral lymph nodes or extended lateral lymph nodes dissection for lying rectal cancer is a controversial topic. Associated with a much higher rate of urinary and sexual dysfunctions as compared to standard TME. Become a routine practice in Japan.
  • 33.  Selection of appropriate therapy for Rectal Cancer. Presently the surgeon has three major curative options: - Local excision, - Sphincter-saving abdominal surgery, - Abdominoperineal Resection, APR. Each patient with rectal cancer should be individually evaluated, and a technical plan is customized to their stage, gender, age, and body habitus.
  • 34. T1 invasion into the submucosa. T2 invasion into the muscularis propria. T3 invasion the mesorectal fat. T4 invasion of other organs.
  • 35. Special circumstances  Laparoscopic colon resection for Cancer* Laparoscopic technique has been used for more than 15 years. Faster return of bowel function, shorter length of stay, less narcotic use. Conversion did not have any negative impact on the oncologic outcome. With adequate experience, laparoscopic colectomy for colon cancer is safe and provides similar outcomes to open colectomy. *- Buunen M, Veldkamp R, Hop W, et al. survival after laparoscopic surgery versus open for colorectal cancer. Lancet oncol, 2009;10:44-52.
  • 36. Special circumstances  Acute obstruction The associated bacterial overgrowth coupled with possible impairment of blood flow in the proximal bowel has been the primary factors that have classically dictated resection and proximal diversion. Colonic stent can serve as bridge to elective surgery in patient with operable cancer. Emergency surgery is associated with operative mortalities as high as 23% and reduce quality of life.* *- Morino M, Bertello A, Garbarini A, et al. malignant colonic obstruction managed by endoscopic stent decompression followed by laparoscopic coloctomy. Surg Endosc 2002;16:1483-7.
  • 37. Special circumstances  Prophylactic Oophorectomy, The debate continue regarding the relative risk and benefits of a prophylactic oophorectomy in female patient with colorectal cancer. The risk of micro metastatic implants in the ovary increases with tumor stage and approaches the 10%.* *-Mackeigan JM, Ferguson JA. Prophylactic oophorectomy and colorectal cancer in premenopausal patients. Dis Colon Rectum 1979;22:401-5.
  • 38. Special circumstances  Colon Cancer and AAA. Vascular surgeons preferred to repair the AAA first, whereas the nonvascular surgeons preferred colectomy. Any aneurysm >6 cm should be repaired first or synchronously with the colon resection, to avoid rupture. Endo vascular repair followed by colectomy within the next couple of days, or under a single anesthetic time, and this is being increasingly supported by the literature.* *-Veraldi GF, Minicozzi A, Genco B, et al. endovascular treatment in patient with AAA and synchronous neoplasm. Chr Italy, 2008;60:23-31.
  • 39. Special circumstances  Colon cancer and liver metastases, The risk of simultaneous colectomy and hepatectomy do not appear to be excessive in selected patients operated by expert surgeons, and long term survival rates seem to be similar.* 16% of previously unresectable patients can be down staged and eventually undergo curative resection with as high as 40% 5- years survival.* When metastatic disease is not resectable, upfront chemotherapy without resection of primary lesion may be reasonable approach. *- Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases down staged by chemotherapy: a model long time survival. Ann Surg. 2004;240:644-57.
  • 40. Outcome of surgery for colorectal cancer  Overall 5-years survival rates after major surgery for colorectal cancer are as follow: stage I, 85-100%; stage II, 60-80%; stage III, 30-50%.  The risk of locoregional recurrence following colectomy should be below 5%.
  • 41. Summary  Surgery of colonic cancer has been increasingly better defined and the data clearly support the benefits of wide mesenteric resection, clear radial margins, and resection of adherent adjacent organs.  To allow accurate staging, 12 nodes or more should be examined.  Attention to surgical detail coupled with improved perioperative care strategies, are essential to minimize operative morbidity and mortality.

Editor's Notes

  1. In 2009 150,000 cases were diagnosed and that there were 50,000 deaths from the disease.
  2. Multi step process ..
  3. Fecal DNA and CT colonography…
  4. Scorring system…and staging or classification.
  5. 7257 patient with stage I to III rectal cancer ,,1994-1997.
  6. Adjuvant therapy has recently been shown to improve the result of TME surgery.
  7. The potential benefit is to avoid two laparotomies and operative risk. Delay management of hepatic metastases offers the ability to accurately stage the patient.